BASI Bioanalytical Systems

Bioanalytical Systems, Inc., Announces Change of Time and Location of the Annual Meeting of Shareholders

Bioanalytical Systems, Inc., Announces Change of Time and Location of the Annual Meeting of Shareholders

WEST LAFAYETTE, Ind., March 11, 2020 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ: BASI), operating as Inotiv (the “Company”, “we” or “our”), today provided notice of a change to the time and location of the Company’s Annual Meeting of Shareholders via the filing of additional proxy materials with the SEC. Click to view the SEC filing.

Due to the emerging public health impact of the coronavirus outbreak (COVID-19), and to support the health and well-being of the Company’s partners, employees and shareholders, the Company is moving the location of the meeting with the hope of minimizing interactions amongst those attending the meeting and the employee population at the Company’s headquarters. The Annual Meeting will be held on Thursday, March 19, 2020, at 10:30 a.m., Eastern Time at the Courtyard Marriott Lafayette, located at 150 Fairington Avenue, Lafayette, Indiana 47905.

The Company urges shareholders to consider voting and submitting proxies in advance of the Annual Meeting, in lieu of attending the meeting in person.

About the Company

Bioanalytical Systems, Inc., operating as Inotiv, is a pharmaceutical development company providing contract research services and monitoring instruments to emerging pharmaceutical companies and the world's leading drug development companies and medical research organizations. The Company focuses on developing innovative services supporting its clients’ discovery and development objectives for improved decision-making and accelerated goal attainment. The Company’s products focus on increasing efficiency, improving data, and reducing the cost of taking new drugs to market. Visit  for more information about the Company.

This release may contain forward-looking statements that are subject to risks and uncertainties including, but not limited to, risks and uncertainties related to changes in the market and demand for our products and services, the development, marketing and sales of products and services, changes in technology, industry and regulatory standards, the timing of acquisitions and the successful closing, integration and business and financial impact thereof, and various market and operating risks, including those detailed in the Company's filings with the U.S. Securities and Exchange Commission.

FOR MORE INFORMATION:

Company Contact:

William Pitchford

Chief Human Resources Officer

Phone: 765.250.9603

 

EN
11/03/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Bioanalytical Systems

MarketLine Department
  • MarketLine Department

Catalent Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances

Summary Marketline's Catalent Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Catalent Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports o...

MarketLine Department
  • MarketLine Department

Catalent Inc - Company Profile and SWOT Analysis

Summary Catalent Inc - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Catalent Inc (Catalent) provides advanced delivery technologies and development solutions for drugs, biologics and consumer health products. The company offers complex advanced formulation delivery technol...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Tables: March 20, 2021

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

Bioanalytical Systems, Inc. Announces Corporate Name Change to Inotiv,...

Bioanalytical Systems, Inc. Announces Corporate Name Change to Inotiv, Inc. WEST LAFAYETTE, Ind., March 19, 2021 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (the “Company”, “We”, “Our” or “Inotiv”), a leading provider of nonclinical and analytical contract research services, today announced a change of the Company’s corporate name from Bioanalytical Systems, Inc. to Inotiv, Inc. The name change was approved by the Company’s shareholders on March 18, 2021, at the Company’s annual meeting of shareholders and became effective as of the filing of articles of amendment to th...

 PRESS RELEASE

Bioanalytical Systems, Inc., doing business as Inotiv, Announces Plan ...

Bioanalytical Systems, Inc., doing business as Inotiv, Announces Plan to Expand Service Offerings to Include Cardiovascular Safety Pharmacology WEST LAFAYETTE, Ind., March 17, 2021 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (the “Company”, “We”, “Our” or “Inotiv”), doing business as Inotiv, a leading provider of nonclinical and analytical contract research services, today announced plans to expand the Company’s service offerings to add cardiovascular safety pharmacology capabilities to the existing capabilities for respiratory and central nervous system safety pharmacol...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch